In vivometal-catalyzed SeCT therapy by a proapoptotic peptide

Peni Ahmadi, Kyohei Muguruma, Tsung Che Chang, Satoru Tamura, Kazuki Tsubokura, Yasuko Egawa, Takehiro Suzuki, Naoshi Dohmae, Yoichi Nakao, Katsunori Tanaka*

*この研究の対応する著者

研究成果: Article査読

5 被引用数 (Scopus)

抄録

Selective cell tagging (SeCT) therapy is a strategy for labeling a targeted cell with certain chemical moietiesviaa catalytic chemical transformation in order to elicit a therapeutic effect. Herein, we report a cancer therapy based on targeted cell surface tagging with proapoptotic peptides (Ac-GGKLFG-X; X = reactive group) that induce apoptosis when attached to the cell surface. Using either Au-catalyzed amidation or Ru-catalyzed alkylation, these proapoptotic peptides showed excellent therapeutic effects bothin vitroandin vivo. In particular, co-treatment with proapoptotic peptide and the carrier-Ru complex significantly and synergistically inhibited tumor growth and prolonged survival rate of tumor-bearing mice after only a single injection. This is the first report of Ru catalyst applicationin vivo, and this approach could be used in SeCT for cancer therapy.

本文言語English
ページ(範囲)12266-12273
ページ数8
ジャーナルChemical Science
12
37
DOI
出版ステータスPublished - 2021 10月 7

ASJC Scopus subject areas

  • 化学 (全般)

フィンガープリント

「In vivometal-catalyzed SeCT therapy by a proapoptotic peptide」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル